无锡药明康德新药开发股份有限公司 关于回购注销部分股票通知债权人的公 告

Core Viewpoint - WuXi AppTec plans to repurchase and cancel a portion of its shares to maintain company value and protect shareholder interests, with a total repurchase amount of RMB 1 billion [2][12][15] Group 1: Share Repurchase Details - The company will repurchase A-shares through centralized bidding, with a maximum price of RMB 97.24 per share, which is 150% of the average trading price over the previous 30 trading days [13][24] - The total number of shares to be repurchased is estimated to be approximately 10,283,833 shares, accounting for about 0.3561% of the company's total issued share capital of 2,887,992,582 shares [2][23] - The repurchased shares will be fully canceled, resulting in a reduction of registered capital from RMB 2,887,992,582 to RMB 2,877,708,749 [3][23] Group 2: Meeting and Approval Process - The third board meeting was held on April 8, 2025, where the board unanimously approved the repurchase plan, which does not require further shareholder approval [9][10] - The board's decision was made in response to a 20% decline in the company's A-share price over the last 20 trading days, aiming to enhance investor confidence [12][17] Group 3: Debt Creditor Notification - The company has notified creditors that they have 45 days from the announcement date to declare their claims, ensuring their rights are protected during the share repurchase process [3][29] - Creditors must provide valid documentation to assert their claims, and failure to do so within the specified period will not affect the validity of their claims [4][5]